Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease
Movement Disorders · 2023-07 · 38 (7) · 1262-1272
DOI: 10.1002/mds.29429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 08.05.2023. Verfasst von Sephira G Ryman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neuroscience, The Mind Research Network, Albuquerque, New Mexico, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Background
Cerebrovascular dysfunction in Parkinson's disease (PD) is heterogeneous and may contribute to disease pathophysiology or progression. There is a need to understand the mechanisms by which cerebrovascular dysfunction is altered in participants with PD.
Objectives
The objective of this study is to test the hypothesis that participants with PD exhibit a significant reduction in the ability of the cerebral vessels to dilate in response to vasoactive challenges relative to healthy controls (HC).
Methods
The current study uses a vasodilatory challenge while participants undergo functional magnetic resonance imaging to quantify the amplitude and delay of cerebrovascular reactivity in participants with PD relative to age and sex‐matched HC. An analysis of covariance was used to evaluate differences in cerebrovascular reactivity amplitude and latency between PD participants and HC.
Results
A significant main effect of group was observed for whole‐brain cerebrovascular reactivity amplitude ( F (1, 28) = 4.38, p = 0.046, Hedge's g = 0.73) and latency ( F (1, 28) = 16.35, p < 0.001, Hedge's g = 1.42). Participants with PD exhibited reduced whole‐brain amplitude and increased latencies in cerebrovascular reactivity relative to HC. The evaluation of regional effects indicates that the largest effects were observed in the cuneus, precuneus, and parietal regions.
Conclusions
PD participants exhibited reduced and delayed cerebrovascular reactivity. This dysfunction may play an important role in chronic hypoxia, neuroinflammation, and protein aggregation, mechanisms that could lead to disease progression. Cerebrovascular reactivity may serve as an important biomarker and target for future interventions. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Neuroscience, The Mind Research Network, Albuquerque, New Mexico, USA.
- Nene and Jamie Koch Comprehensive Movement Disorder Center, Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA.
- Department of Mathematics and Statistics, University of New Mexico, Albuquerque, New Mexico, USA.
- Department of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
- Neurology|Medicine, New Mexico VA Health Care System, Albuquerque, New Mexico, USA.
- Movement Disorders Division in the Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
ORCID-Profile: Sephira G Ryman, Kathleen L Poston
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIMH NIH HHS
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Ryman, S. G., Shaff, N., Dodd, A., Nitschke, S., Wertz, C., Julio, K., Suarez Cedeno, G., Deligtisch, A., Erhardt, E., Lin, H., Vakhtin, A., Poston, K. L., Tarawneh, R., Pirio Richardson, S., & Mayer, A. (2023). Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease. Movement Disorders, 38(7), 1262-1272. https://doi.org/10.1002/mds.29429
Vancouver
Ryman SG, Shaff N, Dodd A, Nitschke S, Wertz C, Julio K, et al. Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease. Movement Disorders. 2023;38(7):1262-1272. doi:10.1002/mds.29429
BibTeX
@article{Ryman2023,
author = {Ryman, Sephira G and Shaff, Nicholas and Dodd, Andrew and Nitschke, Stephanie and Wertz, Christopher and Julio, Kayla and Suarez Cedeno, Gerson and Deligtisch, Amanda and Erhardt, Erik and Lin, Henry and Vakhtin, Andrei and Poston, Kathleen L and Tarawneh, Rawan and Pirio Richardson, Sarah and Mayer, Andrew},
title = {Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {7},
pages = {1262--1272},
doi = {10.1002/mds.29429}
}
EUVIMED